The effect of double dose of omeprazole on the course of angina pectoris and treadmill stress test in patients with coronary artery disease - A randomised, double-blind, placebo controlled, crossover trial

International Journal of Cardiology

Volumn 127, Issue 2, 2008, Pages 233-239

  Budzyński, Jacek ^a   Kłopocka, Maria ^a   Pulkowski, Grzegorz ^a   Suppan, Karol ^a   Fabisiak, Jacek ^a   Majer, Marcin ^a   Światkowski, Maciej ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Angina pectoris; Coronary artery disease; Gastroesophageal reflux disease; Omeprazole; Treadmill stress test

Indexed keywords

ANTACID AGENT; GLYCERYL TRINITRATE; OMEPRAZOLE; PLACEBO;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG EFFECT; EXERCISE TEST; FEMALE; GASTROESOPHAGEAL REFLUX; HEART MUSCLE ISCHEMIA; HEART RATE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; TREADMILL; TREATMENT DURATION; TREATMENT RESPONSE;

ANALYSIS OF VARIANCE; ANGINA PECTORIS; ANTI-ULCER AGENTS; CHEST PAIN; CORONARY DISEASE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 44649170856     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.04.079     Document Type: Article

References (42)

1. Mant J., McManus R.J., Oakes R.A., et al. Systematic review and modelling of the investigation of acute and chronic chest pain presenting in primary care. Health Technol Assess 8 iii (2004) 1-158
2. Bass Ch., and Mayou R. ABC of psychological medicine. Chest pain. BMJ 325 (2002) 588-591
3. Kachintorn U. How do we define non-cardiac chest pain?. Gastroenterol Hepatol 20 (2005) S2-S5 [Suppl]
4. Bugiardini R., and Bairey Merz C.N. Angina with "normal" coronary arteries: a changing philosophy. JAMA 293 (2005) 477-484
5. Dickman R., and Fass R. Noncardiac chest pain. Clin Gastroenterol Hepatol 4 (2006) 558-563
6. Katerndahl D. Panic plaques: panic disorder and coronary artery disease in patients with chest pain. J Am Board Fam Pract 17 (2004) 114-126
7. Liuzzo J.P., and Ambrose J.A. Chest pain from gastroesophageal reflux disease in patients with coronary artery disease. Cardiol Rev 13 (2005) 167-173
8. Kim J., Henderson R.A., Pocock S.J., Clayton T., Sculpher M.J., and Fox K.A. RITA-3 Trial Investigators.: health-related quality of life after interventional or conservative strategy in patients with unstable angina or non-ST-segment elevation myocardial infarction: one-year results of the third Randomized Intervention Trial of unstable Angina RITA-3). J Am Coll Cardiol 45 (2005) 221-228
9. Tougas G., Spaziani R., Hollerbach S., et al. Cardiac autonomic function and oesophageal acid sensitivity in patients with non-cardiac chest pain. Gut 49 (2001) 706-712
10. Sarkar S., Thompson D.G., Woolf C.J., Hobson A.R., Millane T., and Aziz Q. Patients with chest pain and occult gastroesophageal reflux demonstrate visceral pain hypersensitivity which may be partially responsive to acid suppression. Am J Gastroenterol 99 (2004) 1998-2006
11. Chauhan A., Mullins P.A., Taylor G., Petch M.C., and Schofield P.M. Cardioesophageal reflex: a mechanism for "linked angina" in patients with angiographically proven coronary artery disease. J Am Coll Cardiol 27 (1996) 1621-1628
12. Świa{ogonek}tkowski M., Budzyński J., Kłopocka M., et al. Suppression of gastric acid production may improve the course of angina pectoris and the results of treadmill stress test in patients with coronary artery disease. Med Sci Monit 10 (2004) CR524-CR529
13. Rasmussen K., Ravnsbaek J., Funch-Jensen P., and Bagger J.P. Oesophageal spasm in patients with coronary artery spasm. Lancet 1 8474 (1986) 174-176
14. Manfrini O., Bazzocchi G., Luati A., Borghi A., Monari P., and Bugiardini R. Coronary spasm reflects inputs from adjacent esophageal system. Am J Physiol Heart Circ Physiol 290 5 (2006) H2085-H2091
15. Mehta A.J., de Caestecker J.S., Camm A.J., and Northfield T.C. Gastro-oesophageal reflux in patients with coronary artery disease: how common is it and does it matter?. Eur J Gastroenterol Hepatol 8 (1996) 973-978
16. Mellow M.H., Simpson A.G., Watt L., Schoolmeester L., and Haye O.L. Esophageal acid perfusion in coronary artery disease. Induction of myocardial ischemia. Gastroenterology 85 (1983) 306-312
17. Laird C., Driscoll P., and Wardrope J. The ABC of community emergency care: chest pain. Emerg Med J 21 (2004) 226-232
18. Fass R. Empirical trials in treatment of gastroesophageal reflux disease. Dig Dis 18 (2000) 20-26
19. Pandak W.M., Arezo S., Everett S., et al. Short course of omeprazole: a better first diagnostic approach to noncardiac chest pain than endoscopy, manometry, or 24-hour esophageal pH monitoring. Clin Gastroenterol 35 (2002) 307-314
20. Bautista J., Fullerton H., Briseno M., Cui H., and Fass R. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain-a randomized, double-blind, placebo-controlled, crossover trial. Aliment Pharmacol Ther 19 (2004) 1123-1130
21. Dickman R., Emmons S., Cui H., et al. The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial. Aliment Pharmacol Ther 22 (2005) 547-555
22. Singh S., Richter J.E., Hewson E.G., et al. The contribution of gastroesophageal reflux to chest pain in patients with coronary artery disease. Ann Intern Med 117 (1992) 824-830
23. Dobrzycki S., Baniukiewicz A., Korecki J., et al. Does gastro-esophageal reflux provoke the myocardial ischemia in patients with CAD?. Int J Cardiol 104 (2005) 67-72
24. Wu E.B., Cooke R., Anggiansah A., Owen W., and Chambers J.B. Are oesophageal disorders a common cause of chest pain despite normal coronary anatomy?. QJM 93 (2000) 543-550
25. Chauhan A., Petch M.C., and Schofield P.M. Cardio-oesophageal reflex in humans as a mechanism for "linked angina". Eur Heart J 17 (1996) 407-413
26. Tutuian R., and Castell D.O. Review article: oesophageal spasm - diagnosis and management. Aliment Pharmacol Ther 23 10 (2006) 1393-1402
27. Talwar V., Wurm P., de Caestecker J.S., and Gershlick A.H. Gastro-oesophageal reflux related pain in ischaemic heart disease: a controlled clinical trial of lansoprazole. Gut 53 Suppl 3 (2004) A62
28. Nishime E.O., Cole C.R., Blackstone E.H., Pashkow F.J., and Lauer M.S. Heart rate recovery and treadmill exercise score as predictors of mortality in patients referred for exercise ECG. JAMA 284 (2000) 1392-1398
29. Reguła J., Kulich K.R., Stasiewicz J., Jasiński B., Carlsson J., and Wiklund I. Burden of illness in Polish patients with reflux disease. Przegl Epidemiol 59 (2005) 75-85
30. Dobrzycki S., Skrodzka D., Musial W.J., et al. Relationship between gastroesophageal reflux disease and myocardial ischemia. Effect of reflux on temporary activity of autonomic nervous system. Rocz Akad Med Bialymst 49 (2004) 93-97
31. Liuzzo J.P., Ambrose J.A., and Diggs P. Proton-pump inhibitor use by coronary artery disease patients is associated with fewer chest pain episodes, emergency department visits and hospitalizations. Aliment Pharmacol Ther 22 (2005) 95-100
32. Weigl M., Gschwantler M., Gatterer E., Finsterer J., and Stollberger C. Reflux esophagitis in the pathogenesis of paroxysmal atrial fibrillation: results of a pilot study. South Med J 96 (2003) 1128-1132
33. Cuomo R., De Giorgi F., Adinolfi L., et al. Oesophageal acid exposure and altered neurocardiac function in patients with GERD and idiopathic cardiac dysrhythmias. Aliment Pharmacol Ther 24 2 (2006) 361-370
34. Budzyński J., Świa{ogonek}tkowski M., Kłopocka M., Fabisiak J., Bujak R., and Sinkiewicz W. Zależność wyników elektrokardiograficznej próby wysiłkowej od pH wewna{ogonek}trzprzełykowego u me{ogonek}żczyzn z nietypowymi bólami w klatce piersiowej. Pol Arch Med Wewn 103 (2000) 135-140
35. Zvenigorodskaia L.A., and Taranchenko IuV. The course of gastroesophageal reflux disease in elderly patients with concomitant ischemic heart disease. Ter Arkh 78 (2006) 42-45
36. Davies H.A., Page Z., Rush E.M., Brown A.L., Lewis M.J., and Petch M.C. Oesophageal stimulation lowers exertional angina threshold. Lancet 1 (1985) 1011-1014
37. Budzyński J., Kłopocka M., Bujak R., Świa{ogonek}tkowski M., and Sinkiewicz W. Autonomic nervous function in Helicobacter pylori infected patients with atypical chest pain studied by analysis of heart rate variability. Eur J Gastroenterol Hepatol 16 (2004) 451-457
38. Yenisehirli A., and Onur R. Positive inotropic and negative chronotropic effects of proton pump inhibitors in isolated rat atrium. Eur J Pharmacol 519 (2005) 259-266
39. Naseri E., and Yenisehirli A. Proton pump inhibitors omeprazole and lansoprazole induce relaxation of isolated human arteries. Eur J Pharmacol 531 (2006) 226-231
40. Świa{ogonek}tkowski M., Budzyński J., Kłopocka M., et al. The effect of eight weeks of rabeprazole therapy on esophageal pH and motility and nitric oxide plasma level in patients with erosive esophagitis. Med Sci Monit 10 (2004) CR-46-CR-51
41. Johansson S., Wallander M.A., Ruigomez A., and Garcia Rodriguez L.A. Is there any association between myocardial infarction, gastro-oesophageal reflux disease and acid-suppressing drugs?. Aliment Pharmacol Ther 18 (2003) 973-978
42. Johnsson F., Weywadt L., Solhaug J.H., Hernqvist H., and Bengtsson L. One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease. Scand J Gastroenterol 33 (1998) 15-20